The Discounted Cash Flow (DCF) valuation of AnaptysBio Inc (ANAB) is (456.04) USD. With the latest stock price at 21.08 USD, the upside of AnaptysBio Inc based on DCF is -2263.4%.
Based on the latest price of 21.08 USD and our DCF valuation, AnaptysBio Inc (ANAB) is a sell. selling AnaptysBio stocks now will result in a potential gain of 2263.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.9% - 8.5% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (886.54) - (311.54) | (456.04) |
| Upside | -4305.6% - -1577.9% | -2263.4% |